These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 10748550)

  • 1. [Reference data on survival of cancer patients in 17 European countries].
    Sant M
    Epidemiol Prev; 2000; 24(1):44-5. PubMed ID: 10748550
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer survival among women.
    Stat Bull Metropol Life Insur Co; 1974 Jun; 55(0):2-5. PubMed ID: 4837469
    [No Abstract]   [Full Text] [Related]  

  • 3. Chances of survival in women with cancer.
    Geriatrics; 1969 Sep; 24(9):57. PubMed ID: 5811747
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer: incidence and deaths in Canada, 1990.
    Gaudette L; Lee J; Silberberger C
    Health Rep; 1993; 5(4):348-54. PubMed ID: 8011953
    [No Abstract]   [Full Text] [Related]  

  • 5. Changing patterns of cancer mortality among the elderly population in Japan.
    Hirose K; Kuroishi T; Inoue M; Tajima K
    Jpn J Clin Oncol; 1992 Dec; 22(6):428-32. PubMed ID: 1291760
    [No Abstract]   [Full Text] [Related]  

  • 6. Trends in survival rates of patients with cancer.
    Cutler SJ; Myers MH; Green SB
    N Engl J Med; 1975 Jul; 293(3):122-4. PubMed ID: 1134519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of nationwide cancer survival statistics in Finland and Norway.
    Hakulinen T
    World Health Stat Q; 1983; 36(1):35-46. PubMed ID: 6659538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of cancer survival in developing countries.
    Sankaranarayanan R; Black RJ; Swaminathan R; Parkin DM
    IARC Sci Publ; 1998; (145):135-73. PubMed ID: 10194635
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer mortality in Europe. Site-specific patterns and trends 1955 to 1974.
    Campbell H
    World Health Stat Q; 1980; 33(4):241-80. PubMed ID: 7467394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socioeconomic differences in cancer incidence and mortality.
    Faggiano F; Partanen T; Kogevinas M; Boffetta P
    IARC Sci Publ; 1997; (138):65-176. PubMed ID: 9353664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.
    Coleman MP; Gatta G; Verdecchia A; Estève J; Sant M; Storm H; Allemani C; Ciccolallo L; Santaquilani M; Berrino F;
    Ann Oncol; 2003; 14 Suppl 5():v128-49. PubMed ID: 14684503
    [No Abstract]   [Full Text] [Related]  

  • 12. Progress in the fight against cancer in EC countries: changes in mortality rates, 1970-90.
    Geddes M; Balzi D; Tomatis L
    Eur J Cancer Prev; 1994 Jan; 3(1):31-44. PubMed ID: 8130714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between leukemia and cancer of various sites based on the international statistics (relationship between leukemia and cancer of the breast, ovary and prostate)].
    Segi M; Kurihara N
    Saishin Igaku; 1969 Nov; 24(11):2239-44. PubMed ID: 5359803
    [No Abstract]   [Full Text] [Related]  

  • 14. Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.
    Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP
    Am J Hematol; 2015 Aug; 90(8):696-701. PubMed ID: 25963924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Some interpretation of regional estimates of the incidence of cancer in France over the period 1980--2005].
    Colonna M; Bossard N; Mitton N; Remontet L; Belot A; Delafosse P; Grosclaude P;
    Rev Epidemiol Sante Publique; 2008 Dec; 56(6):434-40. PubMed ID: 19010627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Survival after cutaneous metastasis: a study of 200 cases].
    Schoenlaub P; Sarraux A; Grosshans E; Heid E; Cribier B
    Ann Dermatol Venereol; 2001 Dec; 128(12):1310-5. PubMed ID: 11908133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Late recurrence of malignant tumours 20 years after diagnosis and treatment].
    Chodorowski Z; Sein Anand J; Jassem J; Kopacz A; Kruszewski W; Emerich J; Senkus-Konefka E
    Przegl Lek; 2007; 64(4-5):372-3. PubMed ID: 17724919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress against cancer?
    Bailar JC; Smith EM
    N Engl J Med; 1986 May; 314(19):1226-32. PubMed ID: 3702918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancer mortality among Swiss migrants in France].
    Wanner P; Bouchardy C; Parkin DM
    Rev Epidemiol Sante Publique; 1995; 43(1):26-36. PubMed ID: 7892514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Life expectancy deficit (LED). A criterion for evaluating the course of malignant tumors. A statistical survey based on 70,231 malignant diseases with special reference to cases with spinal metastases].
    Schmitt O; Kolles H
    Z Orthop Ihre Grenzgeb; 1986; 124(5):587-91. PubMed ID: 3811483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.